Novartis Community

SWX:NOVN Community

1 Narratives written by author
0 Comments on narratives written by author
97 Fair Values set on narratives written by author

AN

AnalystConsensusTarget

Consensus Narrative from 20 Analysts

Pluvicto And Leqvio Expansion Will Sustain Performance Amid Patent Challenges

Key Takeaways Novartis shows strong growth in key brands and anticipates continued pipeline success, potentially boosting future sales and earnings. Expanding innovative therapies and operational efficiencies are expected to offset patent expirations and support net margin expansion.

CHF 95.83

FV

5.4% undervalued

2.34%

Revenue growth p.a.

1

0

75

5 days ago